Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Overview

With decades of experience in the healthcare industry, we provide companies with access to the pharmaceutical market in Central Eastern Europe & Switzerland. Tailor-made medical marketing helps pharma firms to expand their international operations.

News

News news.qq.com 2 years ago
基石药业-B(02616)与Ewopharma就舒格利单抗在中东欧地区和瑞士达成战略合作_腾讯新闻
智通财经APP讯基石药业-B(02616)发布公告与欧洲医药公司Ewopharma达成商业化战略合作将舒格利单抗在中东欧地区的商业化权利授予Ewopharma根据许可及商业化协议协定Ewopharma将获得舒格利单抗在瑞士以及18个中东欧国家(CEE)的商业化权利这包括欧盟成员国保加利亚、克罗地亚、捷克共和国、爱沙尼亚、匈牙利、拉脱...
Read more
Report
Press release Nasdaq 2 years ago
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
PETACH TIKVA, Israel---- Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has expanded its out licensing transaction with
Read more
Report
Press release businesswire 5 years ago
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.